Atomoxetine Hydrochloride

CHEMBL1702 Phase 4 Одобрено Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
291.8 g/mol
LogP
Phase
4

The hydrochloride salt of atomoxetine, a non-stimulant ADHD medication that increases norepinephrine availability in areas of the brain that regulate attention and behavior. It is taken once or twice daily and may take several weeks to reach full effectiveness.

Молекулярная масса

291,8000 g/mol

TPSA

21,30 Ų

Терапевтические области

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Структура

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CNCC[C@@H](Oc1ccccc1C)c1ccccc1.Cl

InChI

InChI=1S/C17H21NO.ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15;/h3-11,17-18H,12-13H2,1-2H3;1H/t17-;/m1./s1

Molecular Formula

C17H22ClNO

HBD / HBA

2 / 2

Вращаемые Связи

6

Тяжёлые Атомы

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

The hydrochloride salt of atomoxetine, a non-stimulant ADHD medication that increases norepinephrine availability in areas of the brain that regulate attention and behavior. It is taken once or twice daily and may take several weeks to reach full effectiveness.

Yes, Atomoxetine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1702. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 54840. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.